Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Praveen Adusumilli"'
Autor:
Praveen Adusumilli, Lingaraj Nayak, Vidya Viswanath, Leela Digumarti, Raghunadha Rao Digumarti
Publikováno v:
South Asian Journal of Cancer, Vol 7, Iss 3, Pp 210-213 (2018)
Introduction: Desisting from disease directed treatment in the past weeks of life is a quality criterion in oncology service. Patients with advanced cancer have unrealistic expectations from chemotherapy and hold on to it as a great source of hope. M
Externí odkaz:
https://doaj.org/article/173048b379374dfdac71b04febc29227
Autor:
Madhav Danthala, Sadashivudu Gundeti, Laxmi Srinivas Maddali, Ashok Pillai, Krishna Chaitanya Puligundla, Raja Praveen Adusumilli
Publikováno v:
South Asian Journal of Cancer, Vol 5, Iss 4, Pp 176-178 (2016)
Introduction: The Philadelphia chromosome (Ph) is the most common cytogenetic abnormality associated with adult acute lymphoblastic leukemia (ALL) occurring in 20% to 40% of patients. It is also detected in 2% to 5% of children with ALL. Historically
Externí odkaz:
https://doaj.org/article/4c9a3c7be0c24a2db996081673044f4e
Autor:
Vijaya Aditya Yadaraju, Vatturi Venkata Satya Prabhakar Rao, Praveen Adusumilli, Sweta Sinha, Muralidhar Bora
Publikováno v:
Indian Journal of Pathology and Oncology. 7:186-190
Lung carcinoma is the most common and lethal malignancy in men. Non-small cell lung carcinoma is more aggressive than small cell lung carcinoma and often presents in advanced stage with metastasis. Cytology, histopathology, immunohistochemistry and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaa60909f8a4da2c3866b98684b56bad
https://doi.org/10.18231/j.ijpo.2020.035
https://doi.org/10.18231/j.ijpo.2020.035
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:HSR19-076
Introduction: Perception of pain and the need to treat it is highly variable, even amongst oncologists. Availability of pain specialists is an added advantage. This is an analysis of prescription patterns of pain medication and its outcome in cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15565d969a85edea2f2ae5cbb83ccca7
https://doi.org/10.6004/jnccn.2018.7117
https://doi.org/10.6004/jnccn.2018.7117
Autor:
Ashok Pillai Karnam, Siva Prasad Kuruva, Meher Lakshmi Konatam, Sadashivudu Gundeti, Stalin Bala, Raghunadharao Digumarti, Lakshmi Srinivas Maddali, Praveen Adusumilli, Madhav Danthala, Krishna Chaitanya Puligundla
Publikováno v:
Clinical lymphoma, myelomaleukemia. 17(7)
Introduction The patent expiration of imatinib mesylate (Gleevec; Novartis) on February 1, 2016, has brought the focus back on generic versions of the drug, and an opportunity to provide a safe and cost-effective alternative. The objective of our stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b16e951c8d42ec37d31e4ac8ff3ae27
https://pubmed.ncbi.nlm.nih.gov/28559151
https://pubmed.ncbi.nlm.nih.gov/28559151
Autor:
Krishna Chaitanya Puligundla, Laxmi Srinivas Maddali, Madhav Danthala, Ashok Pillai, Raja Praveen Adusumilli, Sadashivudu Gundeti
Publikováno v:
South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 5, Iss 4, Pp 176-178 (2016)
South Asian Journal of Cancer, Vol 5, Iss 4, Pp 176-178 (2016)
Introduction: The Philadelphia chromosome (Ph) is the most common cytogenetic abnormality associated with adult acute lymphoblastic leukemia (ALL) occurring in 20% to 40% of patients. It is also detected in 2% to 5% of children with ALL. Historically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00347138657a3adb4b1a5a80a6ac1add
https://pubmed.ncbi.nlm.nih.gov/28032081
https://pubmed.ncbi.nlm.nih.gov/28032081
Autor:
Praveen Adusumilli, Stalin Bala, Sadashivudu Gundeti, Lakshmi Srinivas Maddali, Meher Lakshmi Konatam
Publikováno v:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Context: Advent of trastuzumab has brought tremendous changes in the survival of human epidermal growth factor receptor 2 (Her2)-positive breast cancer patients. Despite the availability of the drug, it is still out of reach for many patients. There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c1b556eed9b9eef51fa81350ff99be8
https://doi.org/10.4103/0971-5851.203511
https://doi.org/10.4103/0971-5851.203511
Autor:
Adusumilli, Praveen1 praveen.adusumilli@yahoo.com, Konatam, Meher Lakshmi1, Gundeti, Sadashivudu1, Bala, Stalin1, Maddali, Lakshmi Srinivas1
Publikováno v:
Indian Journal of Medical & Paediatric Oncology. Jan-Mar2017, Vol. 38 Issue 1, p22-27. 6p.
Publikováno v:
Indian Journal of Hematology & Blood Transfusion; Nov2016 Supplement, Vol. 32, p373-492, 120p